CD4 and neoplasm: When we confirmed the scRNAseq results using flow cytometry, we observed that the overall recruitment of immune cells, including CD4 T cells and CD8 T cells, was not significantly affected by aPD-1 (Figures S1F, G); however, the number of tumor-specific CD8 T cells was increased by aPD-1 (Figure S1H).